Background: The efficacy of a new airway clearance device (Acapella®) has not been previously investigated. Active cycle of breathing techniques (ACBT) is the standard airway clearance technique used in patients with bronchiectasis. Objective: The objective of this study was to compare the efficacy of ACBT with Acapella as methods of airway clearance in adults with stable, productive bronchiectasis. Methods: Twenty patients (7 males), age 58 ± 11 years (mean ± SD), FEV1 64 ± 22% predicted with stable (change of not greater than FEV1 10% predicted during 3 months prior to study), productive (history of expectoration of half an egg cup sputum/day) bronchiectasis attended the respiratory clinic on 3 days. Day 1: 40-min training session on ACBT and Acapella. Days 2 and 3: 30-min treatment session of either ACBT or Acapella. Treatment order was determined by a concealed randomization procedure. The following outcomes were measured before and after treatment spirometry, SpO2 and breathlessness by an independent assessor who was blinded to treatment order. Weight of sputum (during treatment plus 30 min after treatment), number of coughs and patient preference were also recorded. Results: No significant differences were found at baseline indicating that patients were stable. No significant differences were found between weight of sputum expectorated with ACBT treatment and weight of sputum expectorated with Acapella treatment – mean difference 0.54 g (95% CI –0.39 to 1.46). A greater proportion of patients preferred Acapella (14/20). Conclusion: Acapella is as effective a method of airway clearance as ACBT and may offer a user-friendly alternative to ACBT for patients with bronchiectasis.

Keywords:
Bronchiectasis, Airway clearance techniques, Acapella®, Active cycle of breathing techniques
1.
Barker A: Medical progress bronchiectasis. N Engl J Med 2002;346:1383–1393.
2.
Cole PJ: Inflammation: A two-edged sword – The model of bronchiectasis. Eur J Respir Dis Suppl 1986;147:6–14.
3.
O’Neill B, Bradley J, McArdle N, MacMahon J: The current physiotherapy management of patients with bronchiectasis: A UK survey. Int J Clin Pract 2002;56:34–35.
4.
Volsko TA, DiFiore JM, Chatburn RL: Performance comparison of two oscillating positive expiratory pressure devices: Acapella versus flutter. Respir Care 2003;48:124–130.
5.
Howard J, Bradley J, Hewitt O, Elborn S: The active cycle of breathing technique (ACBT) is a more effective method of airway clearance in cystic fibrosis (CF) patients than the test of incremental respiratory endurance. Paediatr Pulmonol 2000;20:304.
6.
Prasad SA, Randall SD, Balfour-Lynn IM: Fifteen-count breathlessness score: an objective measure for children. Pediatr Pulmonol 2000;30:56–62.
7.
Fauroux B, Boule M, Lofaso F, Zerah F, Clement A, Harf A, Isabey D: Chest physiotherapy in cystic fibrosis: Improved tolerance with nasal pressure support ventilation. Pediatrics 1999;103:E32.
8.
Pryor J, Webber B, Hodson M, Batten J: Evaluation of the forced expiration technique as an adjunct to postural drainage in treatment of cystic fibrosis. Br Med J 1979;2:417–418.
9.
Newcombe RG: Improved confidence intervals for the difference between binominal proportions based on paired data. Stat Med 1999;17:2635–2650.
10.
Sutton P, Parker R, Webber B, Newman N, Garland N, Lopez-Vidriero M, et al: Assessment of the forced expiration technique, postural drainage and directed coughing in chest physiotherapy. Eur J Respir Dis 1983;64:62–68.
11.
Bateman J, Newman S, Daunt K, Sheahan N, Pavia D, Clarke S: Is cough as effective as chest physiotherapy in the removal of excessive tracheobronchial secretions? Thorax 1981;36:683–687.
12.
Patterson JE, Bradley JM, Elborn JS: Airway clearance in bronchiectasis: A randomised crossover trial of active cycle of breathing techniques [incorporating postural drainage (PD) and vibration] versus test of incremental respiratory endurance (TIRE). Chronic Resp Dis 2004;1:127–130.
13.
Thompson C, Harrison S, Ashley J, Day K, Smith D: Randomised crossover study of the Flutter device and the active cycle of breathing in non-cystic fibrosis bronchiectasis. Thorax 2002;57:446–448.
© 2005 S. Karger AG, Basel
2005
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.